Uterine Artery Embolization for Symptomatic Leiomyomata
CIRSE STANDARDS OF PRACTICE GUIDELINES
Transcatheter uterine artery embolization (UAE) for treatment of fibroids was first reported by Ravina in 1995. The continuous advance in the field of vascular Interventional Radiology has facilitated UAE, through the development of low profile catheters and particulate emboli such as polyvinyl alcohol particles (PVA), PVA microspheres and trisacryl gelatine microspheres (TAGM). Prospective randomized studies such as the EMMY and REST trial that compare UAE with hysterectomy have proven scientifically that there is a place for UAE in the treatment of women with symptomatic fibroids.